Scientists at Rejuveron Vascular Therapeutics AG, a company specializing in the development of therapies to tackle neurodegeneration, are using INTEGRA’s VIAFLO 384 handheld electronic pipette to ...
Researchers at the University of Zurich in Switzerland are using INTEGRA’s VIAFLO 96/384 multichannel electronic pipette to streamline the experimental workflow of studies on Pseudomonas aeruginosa – ...
INTEGRA has introduced a new plate holder enabling 1536-well pipetting on its VIAFLO 384 electronic handheld pipette. The introduction of this new capability provides screening labs with a unique ...
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows ...
Neuropore Therapies, a San Diego, California based biopharmaceutical company developing novel, small molecule therapeutics for the treatment of neurodegenerative disorders, announced that the company ...